Opioid-Induced Tolerance and Hyperalgesia

被引:0
作者
Sebastiano Mercadante
Edoardo Arcuri
Angela Santoni
机构
[1] Main Regional Center of Supportive/Palliative Care,Palliative/Supportive Care and Rehabilitation
[2] La Maddalena Cancer Center,undefined
[3] MD Anderson,undefined
[4] Regina Elena Cancer Institute,undefined
[5] University of Rome,undefined
来源
CNS Drugs | 2019年 / 33卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Opioids are very potent and efficacious drugs, traditionally used for both acute and chronic pain conditions. However, the use of opioids is frequently associated with the occurrence of adverse effects or clinical problems. Other than adverse effects and dependence, the development of tolerance is a significant problem, as it requires increased opioid drug doses to achieve the same effect. Mechanisms of opioid tolerance include drug-induced adaptations or allostatic changes at the cellular, circuitry, and system levels. Dose escalation in long-term opioid therapy might cause opioid-induced hyperalgesia (OIH), which is a state of hypersensitivity to painful stimuli associated with opioid therapy, resulting in exacerbation of pain sensation rather than relief of pain. Various strategies may provide extra-opioid analgesia. There are drugs that may produce independent analgesic effects. A tailored treatment provided by skilled personnel, in accordance with the individual condition, is mandatory. Any treatment aimed at reducing opioid consumption may be indicated in these circumstances. Interventional techniques able to decrease the pain input may allow a decrease in the opioid dose, thus reverting the mechanisms producing tolerance of OIH. Intrathecal therapy with local anesthetics and a sympathetic block are the most common techniques utilized in these circumstances.
引用
收藏
页码:943 / 955
页数:12
相关论文
共 405 条
[1]  
Breivik H(2013)The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care BMC Public Health 13 1229-1239
[2]  
Eisenberg E(2010)The prevalence of chronic pain in United States adults: results of an Internet-based survey J Pain 11 1230-264
[3]  
O’Brien T(2001)Opioid poorly-responsive cancer pain: part 2: basic mechanisms that could shift dose response for analgesia J Pain Symptom Manag. 21 255-976
[4]  
Johannes CB(2016)Allostatic mechanisms of opioid tolerance beyond desensitization and downregulation Trends Pharmacol Sci. 37 963-E507
[5]  
Le TK(2014)Opioid tolerance—a predictor of increased length of stay and higher readmission rates Pain Physician. 17 E503-1263
[6]  
Zhou X(2016)Opioid abuse in chronic pain—misconceptions and mitigation strategies N Engl J Med. 374 1253-437
[7]  
Johnston JA(1982)Heroin ‘overdose’ death: contribution of drug-associated environmental cues Science. 216 436-894
[8]  
Dworkin RH(2015)Pain among high-risk patients on methadone maintenance treatment J Pain. 16 887-30
[9]  
Mercadante S(2018)Hyperalgesia induced by opioid drugs J Ration Pharmacother Res 4 22-684
[10]  
Portenoy RK(2009)Opioid induced hyperalgesia: clinical implications for the pain practitioner Physician. 12 679-409